Lyell Immunopharma Financial Overview
Lyell Immunopharma's market cap is currently $708.06M. The company's EPS TTM is $-2.13; its P/E ratio is -1.45; Lyell Immunopharma is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-2.37. See an overview of income statement, balance sheet, and cash flow financials.
